Effect of a novel nasal oxytocin spray with enhanced bioavailability on autism: a randomized trial.
Yamasue H, Kojima M, Kuwabara H, Kuroda M, Matsumoto K, Kanai C, Inada N, Owada K, Ochi K, Ono N, Benner S, Wakuda T, Kameno Y, Inoue J, Harada T, Tsuchiya K, Umemura K, Yamauchi A, Ogawa N, Kushima I, Ozaki N, Suyama S, Saito T, Uemura Y, Hamada J, Kano Y, Honda N, Kikuchi S, Seto M, Tomita H, Miyoshi N, Matsumoto M, Kawaguchi Y, Kanai K, Ikeda M, Nakamura I, Isomura S, Hirano Y, Onitsuka T, Kosaka H, Okada T.
Yamasue H, et al. Among authors: seto m.
Brain. 2022 Apr 18;145(2):490-499. doi: 10.1093/brain/awab291.
Brain. 2022.
PMID: 35067719
Clinical Trial.